Search Results 31-40 of 1773 for ���������������������������������������������:PC90���

  1. PLX038 for the Treatment of Metastatic Ovarian, Peritoneal, and Fallopian Tube Cancers - Mayo Clinic

    The purpose of this study is to determine the response rate to PLX-038 in patients with metastatic ovarian, primary peritoneal, and fallopian tube cancers that ...

  2. PubMed - Enzyme Replacement Therapy in a Patient with Gaucher Disease Type III.

  3. A Study to Evaluate Yttrium-90 Therapy for Radiation Lobectomy - Mayo Clinic

    The Patient Group 1 primary objective is to measure the distribution of 90Y glass microspheres throughout the tumor and non-tumor hepatic parenchyma, as ...

  4. A Study of the Safety, Tolerability, and Drug/Body Interactions of C2N-8E12 in People with Progressive Supranuclear Palsy - Mayo Clinic

    The purpose of this study is to evaluate the safety, tolerability and drug/body interactions of C2N-8E12 in patients with progressive supranuclear palsy.

  5. RLY-2608-201-Ph2 Study Of RLY-2608 In PROS And PIK3CA Driven Malformations - Mayo Clinic

    About this study. The purpose of this study is to compare the efficacy and safety of RLY-2608 versus placebo in adult, adolescent, and pediatric ...

  6. Polycystic kidney disease (PKD) Archives - Mayo Clinic News Network

  7. A Study of CC-90002 in Subjects With Acute Myeloid Leukemia (AML) and High-risk Myelodysplastic Syndrome (MDS) - Mayo Clinic

    Study CC-90002-AML-001 is an open-label, Phase 1 dose escalation (Part A) and expansion (Part B), clinical study of CC-90002, administered by intravenous (IV) ...

  8. Tumor Shrinking Nanoparticle used to Fight Cancer and Brain Tumors - Mayo Clinic

    An error occurred, please try again later. Copy for customer care: session ID undefined. Try again.

  10. Dr. Jan Buckner Archives - Mayo Clinic News Network